NIH-funded research Sbir 2 grant

Smartphone video support to help kids and teens take hydroxyurea

Official title: ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)

Funded at Emocha Mobile Health, INC. · NIH-11176086 · Data updated 2026-11-12

This offers a smartphone video program to help children and teens with sickle cell disease take their hydroxyurea medicine regularly.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionEmocha Mobile Health, INC.
NIH-funded
Lab location1 site (Owings Mills, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2026
Funding year2025
Award (this year)$649,256
NIH project number5R44HL169085-03
Project IDNIH-11176086 on NIH RePORTER

Who could benefit from this research

Could help

Children and adolescents with sickle cell disease who are prescribed hydroxyurea and can use (or have caregiver access to) a smartphone are ideal candidates.

Less likely to help

Adults outside the pediatric age range, people not prescribed hydroxyurea, or those without reliable smartphone access are unlikely to benefit from this program.

What this research studies

Using a smartphone app you'll record short videos showing you or your child taking hydroxyurea, get reminder alerts, and receive encouraging feedback from trained observers. The program can include small monetary rewards for meeting medication goals to boost motivation. The team updated the approach after earlier participants had problems with email delivery and inconsistent phone access, and they will carefully track how much people use the app to see who benefits most. The focus is on helping children and adolescents with sickle cell disease make daily medication easier and more reliable.

Why it matters

Potential benefit: If it works, young people with sickle cell disease could take hydroxyurea more consistently and experience fewer painful episodes and hospital visits.

How similar studies have gone: A previous single-arm study of video directly observed therapy showed promising adherence results but had higher-than-expected drop-out and tech-access problems, so more testing is needed.

Where this research is happening

  • Emocha Mobile Health, INC.
    Owings Mills, United States
    Active

Researchers

  • Principal investigator: Seiguer, Sebastian — Emocha Mobile Health, INC.
  • Study coordinator: Seiguer, Sebastian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.